Inhibition of extracellular QSOX1 using monoclonal antibody inhibitors (Grossman et al, 2013, 2016) was found to slow tumor growth and decrease metastasis (Feldman et al, 2020), apparently by modulating ECM properties rather than Golgi redox state. This evidence concerns the gene QSOX1 and neoplasm.